Recruitment

Recruitment Status
Completed
Estimated Enrollment
200

Inclusion Criterias

Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years

Exclusion Criterias

Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study

Summary

Conditions
Chronic Lymphocytic Leukemia
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criterias

Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years

Exclusion Criterias

Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study

Locations

Szeged, 6720
Szolnok, 5004
Budapest, 1125
Nyíregyháza, 4400
Budapest, 1122
...
Szeged, 6720
Szolnok, 5004
Budapest, 1125
Nyíregyháza, 4400
Budapest, 1122
Eger, 3300
Debrecen, 4032
Gyula, 5700
Székesfehérvár, 8000
Miskolc, 3529
Tatabanuya, 2800
Szombathely, 9700
Veszprem, 8200
Pecs, 7624
Budapest, 1083

Tracking Information

NCT #
NCT02080884
Collaborators
Not Provided
Investigators
Study Director: Clinical Trials Hoffmann-La Roche